Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Tuesday, May 19, 2020 6:56:07 AM
It has effected my thinking..Reading Georges comments made a lot of sense..regarding hedging..but hedging when the Amarin PPS is in the 7$-$8 dollar range is not the same as hedging the stock when it was in the high teens as it was in the Du trial..This goes to the issue of whether or not we are looking at a an asymmetrical bet..The Du DC issue was exactly the kind of binary event that hedging was indicated..Nobody in their right mind thought Du would pull off the stunt she did...So if she ruled for Amarin most likely there would have been not much of a price increase as a positive decision was "baked in" to the PPS...On the other hand a bet she would strike down Amarin was essentially disregarded..AND if you bet she would (hedge) as momma did..Then you were going to get paid off..(ie an asymmetrical bet)...At seven dollars..and the Du decision in the rear view mirror there is no one in his right mind that is not afraid the AC might sanctify the Du decision...So by similar reasoning a loss in AC is likely baked in to the PPS and you might not get paid off for you puts..
The asymmetrical bet in this situation. Is not to hedge..because if the AC decides for Amarin then the PPS is going right back up to the high teens..
These are the times that try men's souls...Here is more food for thought about this latest binary event..Binary events always increase volatility and volatility is a very significant factor in determining how much these puts are going to cost you.and how much you are going to be able to sell them for...One of the most important axioms in options.is you should sell volatility..Once the binary event occurs the volatility drops like a lead weight. This is called a volatility skew..So once the event result is known your options will fall in value before you can sell them..Costing momma more of her money...
The message here is You and I should have hedged the Du trial..but hedging the appeals trial probably the best you can Du (do) is sell covered calls..but you you could lose your position if the AC affirms Amarin..
What to do about Du...The stock market is never easy..You are always one trade away from humility..We all make mistakes...
Facts are the asymmetrical bet this time around is to go long..any PPS drop from a negative AC verdict is not going to change our situation very much...The generics are winning and will continue to be winning..That is what the market is expecting..A win is going to be like the R-I trial and will shoot the PPS up. I am planning on holding my shares and not buying puts..If the decision goes against us I expect a price decline..But I believe we will return to these current levels and eventually go higher. Amarin has a lot of turf outside the USA and that has gone discounted,,
The puts are not likely to pay off to any extent..This will be a classic "volatility skew"..Sometimes doing nothing is what you should do..
":>) JL
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM